Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ORION BIOTECH OPPORTUNITIES CORP.

(ORIAU)
 SummaryQuotesChartsNewsCompany 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/15/2021 07/16/2021 07/19/2021 07/20/2021 07/22/2021 Date
10.1(c) 0(c) 10(c) 9.95(c) 10.07(c) Last
542 25 4 844 14 229 1 000 Volume
0.00% -100.00% -0.50% +1.21% Change
More quotes
Company
Orion Biotech Opportunities Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company intends to focus on the biotechnology and life sciences industries. It has no operations and has generated no revenues. 
Sector
Investment Holding Companies
Calendar
-
More about the company
All news about ORION BIOTECH OPPORTUNITIES CORP.
07/14ORION BIOTECH OPPORTUNITIES CORP.(NA : ORIA) added to NASDAQ Composite Index
CI
06/28ORION BIOTECH OPPORTUNITIES : Management's Discussion and Analysis of Financial ..
AQ
05/21ORION BIOTECH OPPORTUNITIES CORP. : Other Events, Financial Statements and Exhib..
AQ
05/13Orion Biotech Opportunities Prices IPO at $10 Per Unit
MT
05/12Orion Biotech Opportunities Corp. has completed an IPO in the amount of $200 ..
CI
02/25Orion Biotech Opportunities Corp. has filed an IPO in the amount of $200 mill..
CI
More news
News in other languages on ORION BIOTECH OPPORTUNITIES CORP.

- No features available -

More news
Chart ORION BIOTECH OPPORTUNITIES CORP.
Duration : Period :
Orion Biotech Opportunities Corp. Technical Analysis Chart | ORIAU | KYG6780C1252 | MarketScreener
Technical analysis trends ORION BIOTECH OPPORTUNITIES CORP.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Managers and Directors
Zuie Chin Huang Chief Executive Officer & Director
Mark Kayal Chief Financial Officer & Secretary
James J. Collins Independent Director
Samuel E. Broder Director, Vice President & General Counsel
Chrystyna Bedrij Vice President
Sector and Competitors
1st jan.Capi. (M$)
ORION BIOTECH OPPORTUNITIES CORP.0.00%252
INVESTOR AB (PUBL)44.40%76 451
CK HUTCHISON HOLDINGS LIMITED6.93%28 373
AB INDUSTRIVÄRDEN (PUBL)25.46%17 109
HAL TRUST29.70%15 290
LIFCO AB (PUBL)0.00%12 838